wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34623856-01CD97ED-CFAB-4EAB-AB62-209E553F34CB
Q34623856-01CD97ED-CFAB-4EAB-AB62-209E553F34CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34623856-01CD97ED-CFAB-4EAB-AB62-209E553F34CB
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
P2860
Q34623856-01CD97ED-CFAB-4EAB-AB62-209E553F34CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34623856-01CD97ED-CFAB-4EAB-AB62-209E553F34CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b26aa6787a52afd20281fc5843b57f86e8e0d25
P2860
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.